Travel Medicine
(Pharmacists) Chikungunya Essentials: A Guide to Prevention and Management
This is a 45-minute, CFPC/CCCEP/OPQ-accredited eCME program for primary care physicians, pharmacists and other travel health practitioners. The goal is to equip healthcare providers with knowledge about the mosquito-borne chikungunya virus, including transmission, risk factors, diagnostic criteria and disease management, while also unveiling new preventative strategies, including vaccines in development, to protect against the chikungunya virus.
DURATION
45 min
PROFESSION
Pharmacy
# OF CREDITS
2
ACCREDITATION
CCCEP, OPQ
EXPIRY DATE
2025-04-16
Chikungunya virus (CHIKV), a mosquito-borne alphavirus, is the causative agent of chikungunya (CHIK) disease, a condition with low mortality but high acute and chronic morbidity resulting in high overall burden of disease. Infection rates of CHIKV have increased in recent years, and this upward trend is expected to continue as vector habitats continue to expand. This program will provide participants with key insights into CHIKV, including its epidemiology, clinical manifestations, diagnosis, current management and preventative strategies, including vaccines in development. The objective is to enable participants to enhance their knowledge of the disease and diagnostic skills, implement effective management strategies and contribute to public health efforts to protect against the virus.
This program has received an educational grant or in-kind support from Valneva.
Faculty
Vivien Brown, MDCM, CCFP, FCFP, NCMP
Alexandre Chadi, Pharm D., M.Sc, CDE
Sherilyn Houle, BSP, PhD
Aisha Khatib, MD CCFP(EM) CTravMed DTM&H CTropMed FISTM
Christine Palmay, HBArtSci, MD, CCFP, FCFP
Dominique Tessier, MD, CCFP, FCFP, FISTM
Learning objectives
Upon completion of this continuing education program, participants will be better able to:
- Explain the epidemiology and burden of chikungunya virus
- Describe the clinical presentation and morbidity of chikungunya virus infection
- Counsel travellers on preventative strategies to reduce mosquito-borne viral infections
- Describe the chikungunya vaccines under development and the potential role of vaccination in preventing chikungunya virus infection
Accreditation
This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 2.0 CEU(s).
CCCEP File Number: 1066-2024-3778-I-P
This continuing educational activity has been accredited by the OPQ; 0.75 continuing education units/credits will be awarded to pharmacists who successfully complete the program.
Accreditation Number: 14004